<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.thecerbatgem.com/2019/11/21/irhythm-technologies-nasdaqirtc-stock-rating-upgraded-by-bidaskclub-3.html"/>
    <meta property="og:site_name" content="The Cerbat Gem"/>
    <meta property="article:published_time" content="2019-11-21T11:58:44+00:00"/>
    <meta property="og:title" content="Irhythm Technologies (NASDAQ:IRTC) Stock Rating Upgraded by BidaskClub"/>
    <meta property="og:description" content="Irhythm Technologies (NASDAQ:IRTC) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, BidAskClub reports. A number of other research analysts have also commented on the company. ValuEngine lowered Irhythm Technologies from a “buy” rating to a “hold” rating in a report […]"/>
  </head>
  <body>
    <article>
      <h1>Irhythm Technologies (NASDAQ:IRTC) Stock Rating Upgraded by BidaskClub</h1>
      <address><time datetime="2019-11-21T11:58:44+00:00">21 Nov 2019, 11:58</time> by <a rel="author" href="https://www.thecerbatgem.com/author/doug" target="_blank">Doug Wharley</a></address>
      <figure>
        <img src="https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&amp;zc=1&amp;src=https://www.marketbeat.com/logos/irhythm-technologies-inc-logo.PNG"/>
      </figure>
      <p>Irhythm Technologies (NASDAQ:IRTC) was upgraded by <a href="https://bidaskclub.com/">BidaskClub</a> from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, <a href="https://www.bidaskclub.com/">BidAskClub</a> reports.</p>
      <p>A number of other research analysts have also commented on the company. <a href="https://www.americanconsumernews.net/scripts/click.aspx?ValuEngine=1&amp;Symbol=IRTC">ValuEngine</a> lowered Irhythm Technologies from a “buy” rating to a “hold” rating in a report on Thursday, November 14th. <a href="https://www.americanconsumernews.net/scripts/click.aspx?Zacks=1">Zacks Investment Research</a> lowered shares of Irhythm Technologies from a “hold” rating to a “sell” rating in a research report on Saturday, November 9th. JPMorgan Chase &amp; Co. boosted their price objective on shares of Irhythm Technologies from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Thursday, August 1st. Oppenheimer began coverage on shares of Irhythm Technologies in a report on Tuesday, October 22nd. They set a “market perform” rating for the company. Finally, BTIG Research set a $90.00 price objective on shares of Irhythm Technologies and gave the stock a “buy” rating in a report on Wednesday, July 31st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $99.56.</p>
      <p>Shares of <a href="https://www.marketbeat.com/stocks/NASDAQ/IRTC/price-target/">IRTC</a> traded down $1.41 during mid-day trading on Tuesday, hitting $69.62. 12,602 shares of the company’s stock were exchanged, compared to its average volume of 386,660. The stock has a market cap of $1.73 billion, a price-to-earnings ratio of -36.94 and a beta of 1.72. The firm has a fifty day moving average of $68.14 and a two-hundred day moving average of $73.88. The company has a quick ratio of 2.59, a current ratio of 2.66 and a debt-to-equity ratio of 2.53. Irhythm Technologies has a twelve month low of $56.24 and a twelve month high of $98.13.</p>
      <p>Irhythm Technologies (NASDAQ:IRTC) last released its quarterly earnings data on Tuesday, November 5th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.40) by ($0.34). The business had revenue of $55.96 million during the quarter, compared to analyst estimates of $53.76 million. Irhythm Technologies had a negative net margin of 26.45% and a negative return on equity of 97.79%. The firm’s revenue for the quarter was up 46.9% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.43) EPS. On average, equities analysts predict that Irhythm Technologies will post -1.96 earnings per share for the current year.</p>
      <p>Institutional investors have recently made changes to their positions in the company. Great Lakes Advisors LLC raised its holdings in shares of Irhythm Technologies by 1.1% in the 3rd quarter. Great Lakes Advisors LLC now owns 72,038 shares of the company’s stock worth $5,339,000 after buying an additional 799 shares in the last quarter. TimesSquare Capital Management LLC lifted its holdings in Irhythm Technologies by 18.2% during the 3rd quarter. TimesSquare Capital Management LLC now owns 698,325 shares of the company’s stock valued at $51,753,000 after purchasing an additional 107,500 shares during the last quarter. BBVA USA Bancshares Inc. bought a new position in Irhythm Technologies during the 3rd quarter valued at about $407,000. Massachusetts Financial Services Co. MA boosted its position in Irhythm Technologies by 25.8% in the third quarter. Massachusetts Financial Services Co. MA now owns 233,325 shares of the company’s stock valued at $17,292,000 after buying an additional 47,896 shares in the last quarter. Finally, Tower Research Capital LLC TRC acquired a new position in Irhythm Technologies in the third quarter valued at about $124,000.</p>
      <p>
        <b>About Irhythm Technologies</b>
      </p>
      <p>iRhythm Technologies, Inc, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias.</p>
      <p>Recommended Story: <a href="https://www.marketbeat.com/market-indexes/HSI/">What is the Hang Seng index?  </a></p>
      <figure>
        <img src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=IRTC"/>
      </figure>
    </article>
  </body>
</html>